These success, along with a past report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the concept of targeting ACKR3 as a novel way to modulate the opioid system, which could open new therapeutic avenues for opioid-related disorders. Conolidine promises to generally be a https://paulz814iga4.spintheblog.com/profile